XML 57 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation
The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by operating expense categories, as follows:
Twelve Months Ended December 31,
202020192018
Cost of revenues$2,409 $2,929 $4,370 
Research and development4,380 4,227 6,055 
Selling, general and administrative4,348 15,094 17,179 
Total stock-based compensation expense$11,137 $22,250 $27,604 
The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by award types, as follows:
Twelve Months Ended December 31,
202020192018
Stock options$1,308 $7,348 $7,368 
Restricted stock awards9,743 14,775 20,216 
Performance Based Cash Units86 127 20 
Total stock-based compensation before taxes11,137 22,250 27,604 
Tax benefit $1,815 $3,455 $5,387 
Schedule of Fair Value Assumptions The weighted-average assumptions used in the Black-Scholes option pricing model are as follows: 
Twelve Months Ended December 31,
202020192018
Expected stock price volatility74.5 %69.6 %65.5 %
Risk-free interest rate1.0 %1.9 %2.6 %
Expected life of options (in years)4.474.344.13
Expected dividend yield0.0 %0.0 %0.0 %
Weighted-average fair value (PSV) of the options$2.79 $3.82 $4.91 
Schedule of Information about Stock Options Outstanding
The following table summarizes information about stock options outstanding as of December 31, 2020: 
OptionsNumber of
Options
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding at December 31, 20194,922 $14.54 
Options Granted2,315 4.84 
Options Exercised— — 
Options Cancelled(2,814)14.32 
Outstanding at December 31, 20204,423 $9.60 4.57$788,413.19 
Vested at December 31, 20201,809 $15.38 2.59$— 
Exercisable at December 31, 20201,809 $15.38 2.59$1,547.85 
Schedule of Unvested Restricted Stock and Performance Shares Activity
A summary of the Company’s unvested restricted stock at December 31, 2020, and changes during the year ended December 31, 2020, is presented below:
Unvested Restricted StockNumber of
Awards
Weighted- Average
Grant Date
Fair Value
Unvested at December 31, 20193,375 $8.68 
Granted301 4.90 
Vested(1,341)9.11 
Forfeited(825)7.79 
Unvested at December 31, 20201,510 $7.05 
A summary of the Company’s unvested performance-based cash units at December 31, 2020 and changes during the year ended December 31, 2020, is presented below:
Unvested Cash UnitsNumber of
Awards

Period end
Fair Value
Unvested at December 31, 20191,046 $4.75 
Granted1,391 — 
Vested— — 
Forfeited(1,530)— 
Unvested at December 31, 2020907 $4.70